Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06212557 · ClinicalTrials.gov registry record · NA

KIOS Mobile App Evaluation

A NA study of Opioid Use Disorder, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
210
Enrollment target
1
Study location

NCT06212557 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 210 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06212557, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
210 participants
Enrollment target
1
Study location

Study Summary

Evaluation of a mobile medical app (KIOS) vs. treatment as usual for the treatment of opioid use disorder (OUD).

Conditions Studied

Interventions

  • DEVICE KIOS App
  • BEHAVIORAL KIOS App education
  • BEHAVIORAL Treatment as usual

Study Locations (1)

Texas

  • University of Texas Health Science Center - Department of Psychiatry - San Antonio

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2024-05-02
Est. Completion 2026-05-31
Phase NA

What the Registry Record Tells You About NCT06212557

The ClinicalTrials.gov registry entry for NCT06212557 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which KIOS App is the first listed.

NCT06212557 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06212557 about?

NCT06212557 is a clinical study titled "KIOS Mobile App Evaluation". Evaluation of a mobile medical app (KIOS) vs. treatment as usual for the treatment of opioid use disorder (OUD).

What is the current status of trial NCT06212557?

This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2024-05-02. Estimated completion is 2026-05-31.

What conditions does trial NCT06212557 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06212557?

The interventions under investigation include: KIOS App (DEVICE), KIOS App education (BEHAVIORAL), Treatment as usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT06212557?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06212557 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.